Skip to main content
Premium Trial:

Request an Annual Quote

Cambridge Research Biomedicals Extends Life Tech License

NEW YORK (GenomeWeb News) – Peptide and antibody maker Cambridge Research Biochemicals has extended a license agreement with Life Technologies that enables it to use the company's Molecular Probes line of dyes, CRB said today.

The extension of the agreement, originally formed in 2007, extends CRB's license to offer dye-labeled primary antibodies as well as peptides, the Billingham, UK-based firm said.

The extension of the non-exclusive license enables CRB to offer custom primary antibodies using the Molecular Probes fluorescent dye range — including the Alexa Fluor, BODIPY, Oregon Green, and Texas Red fluorophores — to its medical research and drug discovery customers.

Financial terms of the agreement were not released.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.